Buradasınız

Anasayfa » Content

Yenidoğan ve Erken Süt Çocukluğu Döneminde Kronik Böbrek Yetersizliği

Chronic Renal Failure in Newborn and Early Infancy Period

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Chronic renal failure (CRF) is defined as a serum creatinine above 1mg/dl in the 1st year of life, which corresponds to creatinine clearances below 30ml/min per 1.73m². CRF is rarely seen in the newborn period. According to data from the British Association for Pediatric Nephrology, the incidence of CRF in children under 2 years of life is 0.31/million annually. CRF presenting in the newborn period is usually due to congenital or inherited conditions and acquired causes are less common. Renal hypodysplasia, usually associated with obstructive uropathy or bilateral gross vesicoureteral reflux, is the most common cause of congenital CRF. The usual presentation is failure to thrive in the newborn period, with the typical biochemical changes of renal failure suchas increased creatinine levels, hyperpotassemia, hyperuricemia, hyperphosphatemia, hypocalcaemia, and decreased bicarbonate levels together with metabolic acidosis. Renal replacement therapy should be provided to treat children of any age unless they have overwhelmingly serious additional diagnoses. The biggest single problem in most babies with CRF is achieving an adequate energy intake. Peritoneal dialysis is the preferred option for dialysis in early life. Hemodialysis is technically possible, but morbidity and mortality are high.
Bookmark/Search this post with
Abstract (Original Language): 
Yaşamın ilk yılında serum kreatinin değerinin sürekli 1 mg/ dl’nin üzerinde veya kreatinin klirensinin 30 ml/dk/1.73 m²’nin altında olması kronik böbrek yetersizliği (KBY) olarak tanımlanır. Yenidoğan döneminde KBY nadir bir durumdur. British Association for Pediatric Nephrology verilerine göre yaşamın ilk 2 yılında KBY görülme sıklığı yılda milyonda 0.31 vakadır. Yenidoğan döneminde KBY genellikle konjenital nedenlere bağlıdır, edinsel nedenler daha az sıklıkta görülür. En sık nedeni böbrek hipoplazi/displazisidir. Böbrek hipodisplazisi sıklıkla posterior üretral valv (PUV) ve bilateral vezikoüreteral reflü (VUR) gibi konjenital üropatilere ikincil gelişir. Yenidoğan döneminde genellikle tartı alamama ve kreatinin yüksekliği, hiperpotasemi, hiperürisemi, hiperfosfatemi, hipokalsemi ve bikarbonat düşüklüğü ile birlikte metabolik asidoz gibi böbrek yetersizliğinin tipik biyokimyasal değişiklikleri görülür. Bebeğin yaşı ne olursa olsun kontrindikasyon yoksa Renal Replasman Tedavisi (RRT) verilmelidir. Son dönem böbrek yetersizliği olan yenidoğan ve süt çocuklarında en büyük problem yeterli kalori alımının sağlanamamasıdır. RRT verilecek bebeklerde periton diyalizi ilk tedavi seçeneğidir. Hemodiyaliz teknik olarak mümkün olmasına karşın mortalite ve morbiditesi yüksektir.
FULL TEXT (PDF): 
PDF icon arastrmx_172977_18_pp_48-54.pdf
  • 1
48-54
  • Turkish

REFERENCES

References: 

1. Van Dyck M, Bilem N, Proesmans W: Conservative treatment for
chronic renal failure from birth: a 3 year follow-up study. Pediatr
Nephrol 1999;13:865-869
2. Schwartz G, Brion LP, Spitzer A: The use of plasma creatinine
concentration for estimating glomerular filtration rate in infants,
children and adolescents. Pediatr Clin North Am 1987;34:571-
590
3. Potter DE, Holliday MA, Piel CF: Treatment of end stage renal
disease in children: 15-year experience. Kidney Int 1980;18:103-
109
4. Foreman JW, Chan JCM: Chronic renal failure in infants and
children. J Pediatr 1988;113:793-800
5. North American Pediatric Transplant Cooperative Study. 2003
Annual Report. Rockville, MD: The EMMES Corporation, 2003
6. Coulthard MG, Crosier J: Outcome of reaching end stage renal
failure in children under 2 years of age. Arch Dis Child 2002;87:511-
517
7. Bakkaloğlu SA, Ekim M, Sever L, Noyan A, Aksu N, Akman S,
Elhan AH, Yalçınkaya F, Oner A, Kara OD, Calışkan S, Anarat A,
Dusunsel R, Donmez O, Güven AG, Bakkaloglu A, Denizmen Y,
Soylemezoğlu O, Ozcelik G: Chronic peritoneal dialysis in Turkish
children: a multicenter study. Pediatr Nephrol 2005;20(5):644-651
8. Rubenstein M, Meyer R, Bernstein L: Congenital abnormalities
of the urinary system: I. A postmortem survey of developmental
anomalies and acquired congenital lesions in children’s hospital. J
Pediatr 1961;58:356
9. Holmes LB: Prevalence, phenotypic heterogeneity and familial
aspects of bilateral renal agenesis/dysgenesis. In Liss AR (Ed):
Genetics of Kidney Disorders. New York: Alan R. Liss, pp 1989;1-
11
10. Ismaili K, Schurmans T, Wissing KM, Hall M, Van Aelst C, Janssen
F: Early prognostic factors of infants with chronic renal failure
caused by renal dysplasia. Pediatr Nephrol 2001;16(3): 260-264
11. Hiraoka M, Tsukahara H, Ohshima Y, et al: Renal aplasia is the
predominant cause of congenital solitary kidney. Kidney Int
2002;6:1840-1844
12. Farhat W, McLorie G, Bagli D, Khoury A: Greater reliability of
neonatal ultrasonograpy in defining renal hypoplasia with antenatal
hydronephrosis and vesicoureteral reflux. Can J Urol 2002;9:1459-
1463
13. Stock JA, Wilson D, Hana MK: Congenital reflux nephropaty and
severe unilateral fetal reflux. J Urol 1998;160:1017-1018
14. Woolf AS, Thiruchelvam N: Congenital obstructive uropathy: its
origin and contribution to end-stage renal disease in children. Adv
Ren Replace Ther 2001;8:157-163
15. Capisonda R, Phan V, Traubuci J, Daneman A, Balfe JW, Guay-
Woodford LM: Autosomal recessive polycystic kidney disease:
outcomes from a single-centre experience. Pediatr Nephrol
2003;18(2):119-126
16. Holmberg C, Antikainen M, Ronnholm K, Ala Houhala M, Jalanko
H: Management of congenital nephrotic syndrome of the Finnish
type. Pediatr Nephrol 1995;9(1):87-93
17. Holmberg C, Laine J, Ronnholm K, Ala Houhala M, Jalanko H:
Congenital nephrotic syndrome. Kidney Int Suppl. 1996;53:51-56
18. Kaplan BS, Restaino I, Raval DS, et al: Renal failure in the newborn
associated with in utero exposure non-steroidal anti-inflammatory
agents. Pediatr Nephrol 1994;8:700
19. Cinzia M, Anita A: Letter to the editor: Neonatal chronic renal
failure associated with maternal ingestion of Nimesulide as
analgesic. European J Obstetrics and Gynecology and Reproductive
Biology 2004;116:244-245
20. Shroff R, Wright E, Ledermann S, Hutchinson C, Rees L: Chronic
hemodialysis in infants and children under 2 years of age. Pediatr
Nephrol 2003;18:378-383
21. Geary DF: Attitudes of paediatric nephrologists to management of
end-stage renal disease in infants. J Pediatr 1998;133:154-165
22. Rees L: Management of the infant with end-stage renal failure.
Nephrol Dial Transplant 2002;17:1564:1567
23. Kari J, Gonzalez C, Ledermann SE, Shaw V, Rees L: Outcome
and growth of infants with chronic renal failure. Kidney Int
2000;57:1681-1687
24. Ellis EN, Pearson D, Champion B, Wood EG: Outcomes of infants
on chronic peritoneal dialysis. Adv Perit Dial 1995;9:543-548
25. Coleman JE, Watson AR, Rance CH et all: Gastrostomy buttons
for nutritional support on chronic dialysis. Nephrol Dial Transplant
1998;13:2041-2046
26. Ledermann SE, Scanes ME, Fernando ON, Duffy PG, Madden SJ,
Trompeter RS: Long-term outcome of peritoneal dialysis in infants.
J Pediatr 2000;136:24-29
27. Fine RN, Attie KM, Kuntze J, Brown DF, Kohaut EC: On behalf
of the Genetech Collaborative Study Group. Recombinant human
growth hormone in infants and young children with chronic renal
insufficiency. Pediatr Nephrol 1995;9:452-457
28. Haycock GB: Management of acute and chronic renal failure in the
newborn. Seminars in Neonatology 2003;8:325-334

Thank you for copying data from http://www.arastirmax.com